Ancient Protein Helps E. coli Thwart Viral Attack

When engineered to use a four-billion-year-old version of the protein thioredoxin, the bacteria can stall bacteriophage replication, a new study shows.

May 9, 2017
Ashley Yeager

CDCResurrecting ancient proteins in modern E. coli can protect the bacterium from viral infection, scientists reported today (May 9) in Cell Reports. Researchers from Spain engineered the genetic sequences that code for ancestral forms of the protein thioredoxin—including one that would have existed about 4 billion years ago—and found that not only did the old protein function in the cells, but when these bacteria were exposed to the bacteriophage T7, they fended off viral infection.

“This is an interesting strategy that impedes the propagation of the virus,” biochemist Reinhard Sterner of the University of Regensburg in Germany told The Scientist. “It could be a new mode of viral resistance, which is pretty cool.”

The project got its start from an interest in plants. Specifically, Asunción Delgado and colleagues at the University of Granada knew that proteins in plants that aid viral replication haven’t evolved so much so that they can avoid being hijacked by viruses. So, the team wondered whether a different version of a protein, possibly an ancestral form, could keep an organism alive but prevent viral replication.

Thioredoxin was a good test subject: it is found in all modern organisms and is essential for both hosts and invading viruses. In the new study, Delgago and colleagues studied the genetic sequences of a range of microbial organisms, traced their ancestry, and identified the sequences for ancient thioredoxins, dating from 1.5 billion to 4 billion years ago.

Ancient versions of the thioredoxin protein (green circles) don’t allow viral DNA to replicate, but the more modern versions (red circles) do. DELGADO ET AL.In E. coli, thioredoxin circulates electrons to keep vital chemical reactions going. When the team replaced the modern thioredoxin gene in E. coli with ancient sequences, the resulting proteins too moved electrons around, with varying degrees of success. The oldest version didn’t work as well as the more recent ones; but the fact that it dated back to the origin of life itself and still kept the E. coli alive was surprising, said chemist Jose Sanchez-Ruiz, the paper’s senior author, in an interview.

The team then mixed the altered E. coli with bacteriophage T7, which normally recruits thioredoxin in bacteria for help in DNA replication. “The virus inserted its DNA into the bacterium without any trouble. But, when the virus went to recruit thioredoxin for its own purposes, that was a problem,” Sanchez-Ruiz said. Thioredoxins that were roughly 2.5 billion years and older couldn’t be used by the virus for DNA replication. The team also tried the experiment with the human form of thioredoxin, which prevented the virus from replicating, too.

Swapping a protein essential to both the host organism and the virus infecting that organism could confer viral resistance. The strategy could be applied to boosting plants’ resistance to viruses, Sanchez-Ruiz said.

“A big hurdle [to deploying ancient proteins in crops] that must be overcome is that the parts of the protein that do not interact with the pathogen do evolve, albeit more slowly than the pathogen-associated parts,” wrote Michael Harms, an evolutionary biophysicist at the University of Oregon, in an email to The Scientist. “As a result, ancestral proteins do not necessarily directly replace their modern counter parts.”

Harms explained that in commercial plants, growth rate, taste, color, and a number of other traits are important. An ancestral gene might compromise one of the many desired traits, even though it might protect against infection. “Because of this, I suspect that ancestral proteins may be a starting point for engineering more resistant plants rather than a standalone, turn-key solution.”

A. Delgado et al., “Using resurrected ancestral proviral proteins to engineer virus resistance.” Cell Reports, doi:10.1016/j.celrep.2017.04.037, 2017.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.